Preemptive Analgesic Effects of Popliteal Sciatic Nerve Block in Patients With Bilateral Hallux Valgus Surgery

Sponsor
Asan Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT03414593
Collaborator
(none)
20
1
2
11.9
1.7

Study Details

Study Description

Brief Summary

The purpose of this study was to investigate the preemptive effect of ultrasound guided popliteal scistic nerve block on postoperative acute pain in patients with bilateral hallux valgus.

After induction of general anesthesia, the leg to be operated first is decided randomly. After the operation of one leg is completed, PSNB is performed on both legs with 0.2% Ropivacaine and surgery is started on the remaining legs.

When the surgery is over, check to see which foot pain begins first, how strong the pain is, and whether there are any side effects.

Condition or Disease Intervention/Treatment Phase
  • Drug: Ultrasound guided popliteal sciatic nerve block with 0.2% ropivcaine
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients who underwent surgery on both feet at the same time. One foot is performed before surgery and the other is performed after surgery.Patients who underwent surgery on both feet at the same time. One foot is performed before surgery and the other is performed after surgery.
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Prospective, Randomized, Single Blind Trial of Preemptive Analgesic Effects of Popliteal Sciatic Nerve Block in Patients With Bilateral Hallux Valgus Surgery
Actual Study Start Date :
Jan 2, 2018
Anticipated Primary Completion Date :
Dec 31, 2018
Anticipated Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: preoperative blocked leg: group preB

ultrasound guided popliteal sciatic nerve block with 0.2% ropivacaine 20ml Before surgical incision

Drug: Ultrasound guided popliteal sciatic nerve block with 0.2% ropivcaine
Ultrasound guided popliteal sciatic nerve block with 0.2% ropivacaine 20ml

Active Comparator: postoperative blocked leg: group postB

ultrasound guided popliteal sciatic nerve block with 0.2% ropivacaine 20ml After surgical incision

Drug: Ultrasound guided popliteal sciatic nerve block with 0.2% ropivcaine
Ultrasound guided popliteal sciatic nerve block with 0.2% ropivacaine 20ml

Outcome Measures

Primary Outcome Measures

  1. Analgesic duration of nerve block [at 0, 0.5, 1, 4, 8, 12 hours after operation. And AM 9 and PM 5 of POD (Post Operative Day) 1]

    The difference of NRS during study time between group preB and group postB The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0: No pain, 1-3: mild pain, 4-6: Moderate pain, 7-10: severe pain, 10: worst pain imaginable.

Secondary Outcome Measures

  1. Difference of analgesic consumption between both group [at 0, 0.5, 1, 4, 8, 12 hours after operation. And AM 9 and PM 5 of POD (Post Operative Day) 1]

    The difference of usage of rescue analgesics during study time between group preB and group postB after the operation

  2. side effect of popliteal sciatic nerve block [at 0, 0.5, 1, 4, 8, 12 hours after operation. And AM 9 and PM 5 of POD (Post Operative Day) 1]

    any other sensation except pain

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. adults between the ages of 20 and 80

  2. bilateral hallux valgus surgery on the same day

  3. ASA class 1 or 2

  4. Patients who have voluntarily agreed in writing to participate in the trial

Exclusion Criteria:
  1. Patient with side effects on local anesthetics or steroids

  2. Patient who are taboo of peripheral nerve block such as blood clotting disorder, infection, etc.

  3. Patients with uncontrolled medical or psychiatric problem

  4. Patient does not agree to participate in the study

  5. Patients who are pregnant or lactating

Contacts and Locations

Locations

Site City State Country Postal Code
1 Asan Medical Center Seoul Songpa-gu Korea, Republic of 05505

Sponsors and Collaborators

  • Asan Medical Center

Investigators

  • Principal Investigator: JongHyuk Lee, md, Asan Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jong Hyuk Lee, clinical assistant professor, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT03414593
Other Study ID Numbers:
  • 2017-0856
First Posted:
Jan 30, 2018
Last Update Posted:
Jan 30, 2018
Last Verified:
Jan 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jong Hyuk Lee, clinical assistant professor, Asan Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 30, 2018